Inhibition of Podocytes DPP4 Activity Is a Potential Mechanism of Lobeliae Chinensis Herba in Treating Diabetic Kidney Disease

• Main Authors: Xinyu Wang (Author), Jiaqing Xiang (Author), Guixiao Huang (Author), Lin Kang (Author), Guangyan Yang (Author), Han Wu (Author), Kewei Jiang (Author), Zhen Liang (Author), Shu Yang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease and has become a serious public health problem worldwide. Dipeptidyl peptidase-4 (DPP4) inhibitors, an emerging drug for the treatment of diabetes, have been found to have renoprotective effects in addition to glucose-lowe...